Miconazole warnings and precautions: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Miconazole}} {{CMG}}; {{AE}} {{AZ}} ==Warnings and Precautions== ===Hypersensitivity=== Allergic reactions, including anaphylactic reactions and hypersens..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
===Hypersensitivity=== | ===Hypersensitivity=== | ||
Allergic reactions, including [[anaphylactic]] reactions and [[hypersensitivity]], have been reported with the administration of miconazole products, including ORAVIG. Discontinue ORAVIG immediately at the first sign of hypersensitivity. | Allergic reactions, including [[anaphylactic]] reactions and [[hypersensitivity]], have been reported with the administration of miconazole products, including ORAVIG. | ||
Discontinue ORAVIG immediately at the first sign of hypersensitivity. | |||
There is '''no information''' regarding '''cross-hypersensitivity''' between miconazole and other azole antifungal agents. | There is '''no information''' regarding '''cross-hypersensitivity''' between miconazole and other azole antifungal agents. | ||
Monitor patients with a history of hypersensitivity to azoles.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3b205e-8526-48a0-afce-ddcef865d907 | publisher = | date = | accessdate = }}</ref> | Monitor patients with a history of hypersensitivity to azoles.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3b205e-8526-48a0-afce-ddcef865d907 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 08:59, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Warnings and Precautions
Hypersensitivity
Allergic reactions, including anaphylactic reactions and hypersensitivity, have been reported with the administration of miconazole products, including ORAVIG.
Discontinue ORAVIG immediately at the first sign of hypersensitivity.
There is no information regarding cross-hypersensitivity between miconazole and other azole antifungal agents.
Monitor patients with a history of hypersensitivity to azoles.[1]
References
Adapted from the FDA Package Insert.